NCT00141791View on ClinicalTrials.gov

Study Evaluating Etanercept in Moderate to Severe Asthma

PHASE2CompletedINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

July 31, 2006

Study Completion Date

July 31, 2006

Conditions

Asthma

Interventions

DRUG

Etanercept

Trial Locations (13)

11570

Rockville Centre

20902

Wheaton

23229

Richmond

27157

Winston-Salem

32308

Tallahassee

33594

Valrico

34233

Sarasota

35209

Birmingham

53792

Madison

70433

Covington

80206

Denver

97213

Portland

02115

Boston

All Listed Sponsors

lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00141791 - Study Evaluating Etanercept in Moderate to Severe Asthma | Biotech Hunter | Biotech Hunter